Latest fraudulent alert - last updated on Apr 2023. To find out more information and how to protect yourself, please click here.

Investment Institute
Macroeconomic Research

No immediate storm ahead, but insurers should use the lull to build portfolio resilience

  • 17 January 2022 (10 min read)

Key points

  • Our central scenario remains positive for 2022
  • The hunt for yield is still top of insurers’ agendas
  • Inflation and interest rate uncertainty remain centre stage
  • Insurers should consider enhancing diversification and risk management
  • For many, 2022 will be a transition year from a regulatory perspective
  • Sustainable investing should expand across all portfolios

Lingering COVID-19-related supply-side disruptions, alongside a significant rebound in consumer demand, are producing supply bottlenecks and an inflation rate not seen for decades. We expect 2022 to be a year of gradual absorption of the pandemic shock, with robust but less spectacular growth, while pressures on global supply gradually decline, contributing to a slowdown in inflation. A gradual convergence of ‘transitory’ inflation rates towards their target would allow central banks to remain prudent with the pace of monetary policy normalisation, making it digestible for investors as currently priced in to bond and equity markets.

This baseline outlook for 2022 is valid on the assumption that most economies continue to supress COVID-19 flare-ups and manage to remain open. It also presupposes a normalisation of the US employment participation rate in easing pressure on wages. There is still uncertainty on the impact of the pandemic on global economic trends, inflation dynamics, suggesting that investors should also plan for more adverse trajectories.

A worse outcome would be even higher inflation and a more aggressive than expected tightening of monetary policy. Additionally, a sharp rise in real yields would derail growth and earnings momentum and deliver a shock to bond and equity markets.

Transitory or not, inflation is back. Monetary policy is being adjusted while quantitative easing support is easing. In our central scenario, a modest increase in interest rates should allow investors to still enjoy decent returns, especially as they catch investment opportunities and follow capital flows allocated to the climate transition.

But market history shows that bouts of volatility are never far away. This has multiple implications for insurance companies, especially when considering the structure of their balance sheets and current developments in regulatory capital and accounting standards.

Related Articles

Macroeconomic Research

Framing the ECB’s rate cutting cycle

Macroeconomic Research

2024’s elections around the world: The who’s who and the so what…

  • by Irina Topa-Serry, Luis Lopez-Vivas, and others
  • 23 January 2024 (7 min read)
Macroeconomic Research

The key drivers of 10-year US Treasury yields

  • by David Page
  • 18 January 2024 (7 min read)

    Disclaimer

    This website is published by AXA Investment Managers Asia Limited (“AXA IM HK”), an entity licensed by the Securities and Futures Commission of Hong Kong (“SFC”), for general circulation and informational purposes only. It does not constitute investment research or financial analysis relating to transactions in financial instruments, nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy, sell or enter into any transactions in respect of any investments, products or services, and should not be considered as solicitation or investment, legal, tax or any other advice, a recommendation for an investment strategy or a personalised recommendation to buy or sell securities under any applicable law or regulation. It has been prepared without taking into account the specific personal circumstances, investment objectives, financial situation, investment knowledge or particular needs of any particular person and may be subject to change at any time without notice. Offering may be made only on the basis of the information disclosed in the relevant offering documents. Please consult independent financial or other professional advisers if you are unsure about any information contained herein.

    Due to its simplification, this publication is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee such opinions, estimates and forecasts made will come to pass. Actual results of operations and achievements may differ materially. Data, figures, declarations, analysis, predictions and other information in this publication is provided based on our state of knowledge at the time of creation of this publication. Information herein may be obtained from sources believed to be reliable. AXA IM HK has reasonable belief that such information is accurate, complete and up-to-date. To the maximum extent permitted by law, AXA IM HK, its affiliates, directors, officers or employees take no responsibility for the data provided by third party, including the accuracy of such data. This material does not contain sufficient information to support an investment decision. References to companies (if any) are for illustrative purposes only and should not be viewed as investment recommendations or solicitations.

    All investment involves risk, including the loss of capital. The value of investments and the income from them can fluctuate and that past performance is no guarantee of future returns, investors may not get back the amount originally invested. Investors should not make any investment decision based on this material alone. 

    Some of the services listed on this Website may not be available for offer to retail investors.

    This Website has not been reviewed by the SFC. © 2023 AXA Investment Managers. All rights reserved.